24 Mar 2020
SPI Pharma Expands Mannogem® Mannitol Product Portfolio to support the development, manufacture and administration of oral dosage forms.
Author: admintech | Filed under: Press ReleaseWILMINGTON, Del., March 24, 2020 /PRNewswire/ — SPI Pharma has announced an expansion of its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Mannogem XL Opal, Mannogem XL Ruby, Mannogem Emerald, and Mannogem Onyx. SPI Pharma has…